Annual Statements Open main menu

Digital Locations, Inc. - Quarter Report: 2008 September (Form 10-Q)

form10q.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q
(Mark One)

T   QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED September 30, 2008
 
¨ TRANSITION REPORT UNDER SECTION13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
FOR THE TRANSITION PERIOD FROM __________ TO __________
COMMISSION FILE NUMBER: 333-144931

CARBON SCIENCES, INC.
(Name of registrant in its charter)

Nevada
 
20-5451302
(State or other jurisdiction of incorporation or
organization)
 
(I.R.S. Employer Identification No.)
 
5511C  Ekwill Street, Santa Barbara, California 93111
(Address of principal executive offices) (Zip Code)

Issuer’s telephone Number: (805) 456-7000

WITH COPIES TO:

Gregory Sichenzia, Esq.
Marcelle S. Balcombe, Esq.
Sichenzia Ross Friedman Ference LLP
61 Broadway, 32 nd Flr.
New York, New York 10006
(212) 930-9700

Indicate by check mark whether the registrant (1) has filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  x   No  o
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer o
 
Accelerated filer o
Non-accelerated filer o
 
Smaller reporting company x
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  o   No  x
 
The number of shares of registrant’s common stock outstanding, as of November 12, 2008 was 148,342,000.
 

1



 
 
CARBON SCIENCES, INC. 
INDEX

PART I: FINANCIAL INFORMATION
   
ITEM 1:
 
FINANCIAL STATEMENTS (Unaudited)
 
3
   
Balance Sheets
 
3
   
Statements of Operations
 
4
   
Statements of Cash Flows
 
5
   
Notes to the Financial Statements
 
6-8
ITEM 2:
 
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
9
ITEM 3 :
 
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
 
12
ITEM 4:
 
CONTROLS AND PROCEDURES
 
12
PART II: OTHER INFORMATION
   
Item 1
 
LEGAL PROCEEDINGS
 
13
ITEM 1A :
 
RISK FACTORS
 
13
ITEM 2
 
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
 
13
ITEM 3
 
DEFAULTS UPON SENIOR SECURITIES
 
13
ITEM 4
 
SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
 
13
ITEM 6:
 
EXHIBITS
 
13
SIGNATURES
 
14
 

2


 

PART I    – FINANCIAL INFORMATION  
 
ITEM 1. FINANCIAL STATEMENTS
 
CARBON SCIENCES, INC.
(A Development Stage Company)
 
BALANCE SHEETS
   
(Unaudited)
       
   
September 30, 2008
   
December 31, 2007
 
             
ASSETS
           
             
CURRENT ASSETS
           
  Cash
  $ 26,733     $ 9,539  
  Certificates of deposit
    139,119       821,505  
  Other receviable
    2,400       -  
  Prepaid expenses
    9,167       122,488  
                 
                        Total Current Assets
    177,419       953,532  
                 
PROPERTY & EQUIPMENT, at cost
               
   Machinery & equipment
    71,498       20,599  
   Computer equipment
    17,559       17,559  
   Mobile vehicle
    40,252       40,252  
      129,309       78,410  
   Less accumulated depreciation
    (22,272 )     (9,637 )
                 
                        Net Property and Equipment
    107,037       68,773  
                 
OTHER ASSETS
               
  Patent
    5,425       -  
                 
                        Total Other Assets
    5,425       -  
                 
                       TOTAL ASSETS
  $ 289,881     $ 1,022,305  
                 
                 
LIABILITIES AND SHAREHOLDERS' EQUITY
               
                 
CURRENT LIABILITIES
               
    Accounts payable
  $ 36,995     $ 2,676  
    Accrued expenses
    -       8,074  
                 
                       TOTAL CURRENT LIABILITIES
    36,995       10,750  
                 
SHAREHOLDERS' EQUITY EQUITY
               
   Common Stock, $0.001 par value;
               
   500,000,000 authorized common shares
               
   148,342,000 shares issued and outstanding, respectively
    148,342       148,342  
   Additional paid in capital
    2,155,533       2,155,533  
   Accumulated deficit during the development stage
    (2,050,989 )     (1,292,320 )
                 
                      TOTAL SHAREHOLDERS' EQUITY
    252,886       1,011,555  
                 
                      TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
  $ 289,881     $ 1,022,305  
 
The accompanying notes are an integral part of these financial statements
 
3

 
 
CARBON SCIENCES, INC.
(A Development Stage Company)
 
STATEMENTS OF OPERATIONS
(Unaudited)

 
                           
From Inception on
 
                           
August 25,2006
 
   
Three Months Ended September 30,
   
Nine Months Ended September 30,
   
through
 
   
2008
   
2007
   
2008
   
2007
   
September 30, 2008
 
                               
                               
REVENUE
  $ -     $ -     $ -     $ -     $ -  
                                         
OPERATING EXPENSES
                                       
  Selling and marketing expenses
    133,612       74,181       441,694       483,228       1,428,266  
  General and administrative expenses
    49,002       26,058       127,012       151,253       372,333  
  Research and development
    104,493       35,425       194,943       40,925       265,626  
  Depreciation expense
    4,212       1,463       12,635       4,390       22,272  
                                         
TOTAL OPERATING EXPENSES
    291,319       137,127       776,284       679,796       2,088,497  
                                         
LOSS FROM OPERATIONS BEFORE  OTHER INCOME/(EXPENSES)
    (291,319 )     (137,127 )     (776,284 )     (679,796 )     (2,088,497 )
                                         
OTHER INCOME/(EXPENSE)
                                       
  Interest income
    3,288       10,548       17,615       10,548       39,119  
  Interest expense
    -       (332 )     -       (1,533 )     (1,611 )
                                         
TOTAL OTHER INCOME/(EXPENSES)
    3,288       10,216       17,615       9,015       37,508  
                                         
NET LOSS
  $ (288,031 )   $ (126,911 )   $ (758,669 )   $ (670,781 )   $ (2,050,989 )
                                         
BASIC AND DILUTED LOSS PER SHARE
  $ (0.00 )   $ (0.00 )   $ (0.01 )   $ (0.00 )        
                                         
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING
                                 
      BASIC AND DILUTED
    148,342,000       146,185,870       148,342,000       140,025,260          
 
The accompanying notes are an integral part of these financial statements
 
4

 
CARBON SCIENCES, INC.
(A Development Stage Company)
 
STATEMENT OF SHAREHOLDERS' EQUITY

 
                     
Deficit
       
                     
Accumulated
 
 
 
               
Additional
   
during the
       
   
Common stock
   
Paid-in
   
Development
   
 
 
   
Shares
   
Amount
   
Capital
   
Stage
   
Total
 
                               
Balance at December 31, 2007
    148,342,000     $ 148,342     $ 2,155,533     $ (1,292,320 )   $ 1,011,555  
                                         
Net Loss (unaudited)
    -       -       -       (758,669 )     (758,669 )
                                         
Balance at September 30, 2008 (unaudited)
    148,342,000     $ 148,342     $ 2,155,533     $ (2,050,989 )   $ 252,886  
 
The accompanying notes are an integral part of these financial statements
 
5

 
 
CARBON SCIENCES, INC.
(A Development Stage Company)
 
STATEMENTS OF CASH FLOWS
(Unaudited)

 
               
From Inception on
 
               
August 25,2006
 
   
Nine Months Ended
   
through
 
   
September 30, 2008
   
September 30, 2007
   
September 30, 2008
 
CASH FLOWS FROM OPERATING ACTIVITIES:
                 
Net loss
  $ (758,669 )   $ (670,781 )   $ (2,050,989 )
Adjustment to reconcile net loss to net cash
                       
  used in operating activities
                       
 Depreciation expense
    12,635       4,390       22,272  
 Stock issuance for services
    -       153,450       -  
         (Increase) Decrease in:
                       
             Other receivable
    (2,400 )     -       (2,400 )
             Prepaid expenses
    113,321       (26,956 )     (9,167 )
             Other asset
    (5,425 )     -       (5,425 )
        Increase (Decrease) in:
                       
             Accounts payable
    34,319       37,621       36,995  
             Accrued expenses
    (8,074 )     (15,564 )     -  
                         
NET CASH USED IN OPERATING ACTIVITIES
    (614,293 )     (517,840 )     (2,008,714 )
                         
CASH FLOWS FROM INVESTING ACTIVITIES:
                 
   Investment in certificates of deposit
    682,386       (910,548 )     (139,119 )
Purchase of equipment
    (50,899 )     (40,252 )     (129,309 )
                         
NET CASH PROVIDED/(USED) IN INVESTING ACTIVITIES
    631,487       (950,800 )     (268,428 )
                         
CASH FLOWS FROM FINANCING ACTIVITIES:
                       
    Advances from officer
    -       -       73,000  
    Loan from investor
    -       -       160,000  
    Repayment of advances and loans
    -       -       (233,000 )
 Proceeds from issuance of common stock
    -       1,497,300       2,303,875  
                         
NET CASH PROVIDED BY FINANCING  ACTIVITIES
    -       1,497,300       2,303,875  
                         
NET INCREASE IN CASH
    17,194       28,660       26,733  
                         
CASH, BEGINNING OF PERIOD
    9,539       75,142       -  
                         
CASH, END OF PERIOD
  $ 26,733     $ 103,802     $ 26,733  
                         
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
                 
   Interest paid
  $ -     $ 332     $ 1,611  
   Taxes paid
  $ 59     $ 800     $ 800  
                         
                         
SUPPLEMENTAL SCHEDULE FOR NON-CASH TRANSACTIONS
                 
During the nine months ended September 30, 2007, the Company
                 
issued 1,472,000 shares of common stock for services at a price of $0.10
                 
and 500,000 shares of common stock for services at a price of $0.15.
                 
 
The accompanying notes are an integral part of these financial statements
 
6

 
 
CARBON SCIENCES, INC.
(A Development Stage Company)
NOTES TO FINANCIAL STATEMENTS-UNAUDITED
SEPTEMBER 30, 2008
 
 
 

1.     Basis of Presentation
The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included.  Operating results for the nine month period ended September 30, 2008 are not necessarily indicative of the results that may be expected for the year ending December 31, 2008.  For further information refer to the financial statements and footnotes thereto included in the Company's Form 10-K for the year ended December 31, 2007.

Going Concern
The accompanying financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business.  The accompanying financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern.  The Company does not generate significant revenue, and has negative cash flows from operations, which raise substantial doubt about the Company’s ability to continue as a going concern.  The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, additional cash infusion.  The Company has obtained funds from its shareholders since its’ inception , and believes this funding will continue, and is also actively seeking new investors.  Management believes the existing shareholders and the prospective new investors will provide the additional cash needed to meet the Company’s obligations as they become due, and will allow the development of its core of business.

2.   SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

This summary of significant accounting policies of Carbon Sciences, Inc. is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements.

Development Stage Activities and Operations
The Company is in its initial stages of formation and has insignificant revenues. FASB #7 defines a development stage activity as one in which all efforts are devoted substantially to establishing a new business and even if planned principal operations have commenced, revenues are insignificant.

Revenue Recognition
The Company will recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. To date, the Company has had no revenues and is in the development stage.

Cash and Cash Equivalent
The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.


7


 
CARBON SCIENCES, INC.
(A Development Stage Company)
NOTES TO FINANCIAL STATEMENTS-UNAUDITED
SEPTEMBER 30, 2008
 

2. 
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
 
Loss per Share Calculations
The Company adopted Statement of Financial Standards (“SFAS”) No. 128 for the calculation of “Loss per Share”.  SFAS No. 128 dictates the calculation of basic earnings per share and diluted earnings per share. Basic earnings per share are computed by dividing income available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company’s diluted loss per share is the same as the basic loss per share for the period ended September 30, 2008 as the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss.

Reclassification
The expenses for the nine  months ended September 30, 2007 were reclassified to conform with the expenses for the nine months ended September 30, 2008.

3.
CAPITAL STOCK

At September 30, 2008, the Company’s authorized stock consists of 500,000,000 shares of common stock, par value $0.001 per share. During the nine months ended September 30, 2007, the Company through a private placement issued 17,625,000 shares of common stock for cash of $1,762,500 at a price of $0.10. The private placements, was made in reliance upon an exemption from registration under Rule 506 of Regulation D promulgated under Section 4(2) of the Securities Act of 1933; Also, the Company issued 1,472,000 shares of common stock at a  price of $0.10 per share for cash and 500,000 shares of common stock at a price of $0.15 per share for services;

4.
INCOME TAXES

 
The Company files income tax returns in the U.S. Federal jurisdiction, and the state of California. With few exceptions, the Company is no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2005.

 
The Company adopted the provisions of FASB Interpretation No. 48, Accounting for Uncertainty in Income Taxes, on January 1, 2007.  Deferred income taxes have been provided by temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for tax purposes. To the extent allowed by GAAP, we provide valuation allowances against the deferred tax assets for amounts when the realization is uncertain.

 
Included in the balance at September 30, 2008, are no tax positions for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility.  Because of the impact of deferred tax accounting, other than interest and penalties, the disallowance of the shorter deductibility period would not affect the annual effective tax rate but would accelerate the payment of cash to the taxing authority to an earlier period.

 
The Company's policy is to recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses.

 
8

 
I TEM 2:  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
Certain statements contained herein constitute forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of such terms, or other comparable terminology. All statements other than statements of historical fact made in this report are forward looking. In particular, the statements herein regarding industry prospects and future results of operations or financial position are forward-looking statements. Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements as a result of certain factors, including, but not limited to, risks associated with the integration of businesses following an acquisition, competitors with broader product lines and greater resources, emergence into new markets, the termination of any of our significant contracts, our inability to maintain working capital requirements to fund future operations, or our inability to attract and retain highly qualified management, technical and sales personnel.

OVERVIEW
 
Carbon Sciences is currently developing a technology to convert the greenhouse gas, carbon dioxide (CO2), into gasoline and other fuels.
 
The fuels we use today, such as gasoline and jet fuel, are made up of chains of hydrogen and carbon atoms aptly called hydrocarbons. In general, the greater the number of carbon atoms there are in a hydrocarbon molecule, the greater the energy content of that fuel. For example, gasoline has hydrocarbons with 7 to 10 carbon atoms and jet fuel has 10 to 16 carbon atoms. Hydrocarbons are naturally occurring in fuel sources such as petroleum and natural gas. To create fuel, hydrogen and carbon atoms must be bonded together to create hydrocarbon molecules.
 
Our CO2-to-Fuel technology directly transforms CO2 and H20 (water) into low level hydrocarbons.  These low level hydrocarbons can then be easily used to produce high level fuels, such as gasoline and jet fuel with readily available technology.  The key to our CO2-to-Fuel technology lies in a proprietary multi-step biocatalytic process. Instead of using expensive inorganic catalysts, such as zinc, gold or zeolite, with traditional high energy catalytic chemical processes, our process uses inexpensive, renewable biomolecules to catalyze certain chemical reactions required to transform CO2 into basic hydrocarbon building blocks. Of greatest significance, our process occurs at low temperature and low pressure, thereby requiring far less energy than other approaches.
 
The energy efficient biocatalytic processes we are exploiting in our technology actually occur in all living organisms where carbon atoms, extracted from CO2, and hydrogen atoms, extracted from H2O, are combined to create hydrocarbon molecules.  Our breakthrough technology allows these processes to operate on a very large industrial scale through advance nano-engineering of the biocatalysts and highly efficient process design.
 
Our corporate mission is to enable a sustainable world of fuel consumption and climate stability by transforming CO2 into fuel. When commercially developed, our CO2-to-Fuel technology can be used to transform CO2 emitted from fossil fuel power plants into gasoline, to power our cars.
 
We are also developing technology to transform carbon dioxide (CO2) into high value, earth-friendly products. We call this technology GreenCarbon Technology.  Our management believes that energy and CO2 intensive industries, such as paper production, will welcome this innovative clean technology because it offers two very important benefits lower cost and carbon neutrality.
 
Corporate Overview
 
We were incorporated in the State of Nevada on August 25, 2006, as Zingerang, Inc. Our name was changed to Carbon Sciences, Inc. on April 9, 2007. Our principal executive offices are located at 5511C Ekwill Street, Santa Barbara, California 93111, and our telephone number is (805) 456-7000. Our fiscal year end is December 31
 

9

 
Critical Accounting Policies
 
Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to impairment of property, plant and equipment, intangible assets, deferred tax assets and fair value computation using the Black Scholes option pricing model. We base our estimates on historical experience and on various other assumptions, such as the trading value of our common stock and estimated future undiscounted cash flows, that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions; however, we believe that our estimates, including those for the above-described items, are reasonable.
 
Revenue Recognition

Revenue on product sales is recognized when persuasive evidence of an arrangement exists, such as when a purchase order or contract is received from the customer, the selling price is fixed, title to the goods has changed and there is a reasonable assurance of collection of the sales proceeds.  We obtain written purchase authorizations from our customers for a specified amount of product at a specified price and consider delivery to have occurred at the time of shipment.  Revenue is recognized at shipment and we record a reserve for estimated sales returns, which is reflected as a reduction of revenue at the time of revenue recognition. We defer revenue on products sold directly to the consumer with a fifteen day right of return. Revenue is recognized upon the expiration of the right of return.

Revenues from research and development activities relating to firm fixed-price contracts are generally recognized on the percentage-of-completion method of accounting as costs are incurred (cost-to-cost basis).  Revenues from research and development activities relating to cost-plus-fee contracts include costs incurred plus a portion of estimated fees or profits based on the relationship of costs incurred to total estimated costs.  Contract costs include all direct material and labor costs and an allocation of allowable indirect costs as defined by each contract, as periodically adjusted to reflect revised agreed upon rates. These rates are subject to audit by the other party. 
  
Use of Estimates

In accordance with accounting principles generally accepted in the United States, management utilizes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. These estimates and assumptions relate to recording net revenue, collectibility of accounts receivable, useful lives and impairment of tangible and intangible assets, accruals, income taxes, inventory realization, stock-based compensation expense and other factors. Management believes it has exercised reasonable judgment in deriving these estimates. Consequently, a change in conditions could affect these estimates.

Fair Value of Financial Instruments

The Company's cash, cash equivalents, investments, accounts receivable and accounts payable are stated at cost which approximates fair value due to the short-term nature of these instruments.

Recently Issued Accounting Pronouncements

In December 2004, the Financial Accounting Standards Board issued two FASB Staff Positions - FSP FAS 109-1, Application of FASB Statement 109 "Accounting for Income Taxes" to the Tax Deduction on Qualified Production Activities Provided by the American Jobs Creation Act of 2004, and FSP FAS 109-2 Accounting and Disclosure Guidance for the Foreign Earnings Repatriation Provision within the American Jobs Creation Act of 2004. Neither of these affected the Company as it does not participate in the related activities.
 

10

 
 
In May 2005, the FASB issued FASB Statement No. 154, “Accounting Changes and Error Corrections.” This new standard replaces APB Opinion No. 20, “Accounting Changes, and FASB Statement No. 3, Reporting Accounting Changes in Interim Financial Statements,” and represents another step in the FASB’s goal to converge its standards with those issued by the IASB. Among other changes, Statement 154 requires that a voluntary change in accounting principle be applied retrospectively with all prior period financial statements presented on the new accounting principle, unless it is impracticable to do so. Statement 154 also provides that (1) a change in method of depreciating or amortizing a long-lived non-financial asset be accounted for as a change in estimate (prospectively) that was effected by a change in accounting principle, and (2) correction of errors in previously issued financial statements should be termed a “restatement.” The new standard is effective for accounting changes and correction of errors made in fiscal years beginning after December 15, 2005. Early adoption of this standard is permitted for accounting changes and correction of errors made in fiscal years beginning after June 1, 2005. The Company has evaluated the impact of the adoption of Statement 154 and does not believe the impact will be significant to the Company's overall results of operations or financial position

RESULTS OF OPERATIONS – THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2008 COMPARED TO THE THREE AND NINE MONTHS ENDED SEPTEMBER  30, 2007
 
Selling and Marketing Expenses
 
Selling and Marketing ("S&M") expenses increased by $59,431or 80.12% to $133,612 for the three months ended September 30, 2008, compared to the prior period. S&M expenses decreased by $(41,534) or 8.60% to $441,694 for the nine months ended September 30, 2008, compared to the prior period. The increase in S&M expenses for the three month period was due to an increase in salaries and market exposure expense. The decrease in S&M expenses for the nine month period was due primarily to a decrease in salaries, professional and consulting fees.
 
General and Administrative Expenses
 
General and administrative ("G&A") expenses increased by $22,944 or 88.05% to $49,002 for the three months ended September 30, 2008, compared to the prior period. G&A expenses decreased by $(24,241) or 16.03% to $127,012 for the nine months ended September 30, 2008, compared to the prior period. The increase in G&A expenses for the three month period was due to increase in the overall operating expenses. The decrease in G&A expenses for the nine month period was due primarily to a decrease in professional fees.
 
Research and Development
 
Research and Development ("R&D") costs increased by $69,068 or 194.97% to $104,943 for the three months ended September 30, 2008, compared to the prior period. R&D costs increased by $154,018 or 376.34% to $194,943 for the nine months ended September 30, 2008, compared to the prior period. The increase in R&D was the result of testing of product alternatives, and consulting fees.
 
Net Loss
 
Net Loss for the three months ended September 30, 2008 was $288,031compared to $126,911 for the prior period. Net Loss for the nine months ended September 30, 2008, was $758,669 compared to $670,781 for the prior period. Currently the Company is in its development stage and had no revenues.
 
Liquidity and Capital Resources
 
As of September 30, 2008, we had $140,424 of working capital as compared to $942,782 as of December 31, 2007. This decrease of $802,358 was due primarily to the use of funds for operating expenses.
 
Net cash flow used in operating activities was $614,293 for the nine months ended September 30, 2008, as compared to net cash used of $517,840 for the prior period. This increase of $96,453 was primarily attributable to an increase in research and development.
 
Net cash provided by investing activities was $631,487 for the nine months ended September 30, 2008, as compared to net cash used of $(950,800) for the prior period. The increase of net cash provided by investing activities was primarily due to withdrawals from certificates of deposits for operating expenses.
 
 
11

 
Net cash provided from financing activities was $0 the nine months ended September 30, 2008, as compared to net cash provided of $1,497,300 for the prior period. From inception to September 30, 2008, we received a total of $2,303,875 from the sale of shares of our common stock through private placements of shares of common stock pursuant to Subscription Agreements, which we entered into with accredited and/or institutional buyers.
 
PLAN OF OPERATION AND FINANCING NEEDS

Our plan of operation within the next twelve months is to utilize our cash balances to continue research and development of our carbon transformation technology and complete a demonstrable prototype. We believe that our current cash and investment balances will be sufficient to support development activity and general and administrative expenses for the next twelve months. Management estimates that it will require additional cash resources during 2008, based upon its current operating plan and condition. We will be investigating additional financing alternatives, including equity and/or debt financing. There is no assurance that capital in any form would be available to us, and if available, on terms and conditions that are acceptable. If we are unable to obtain sufficient funds during the next twelve months, we may be forced to reduce the size of our organization, which could have a material adverse impact on, or cause us to curtail and/or cease, the development of our products.
 
Off-Balance Sheet Arrangements

We do not have any off balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition, revenues, and results of operations, liquidity or capital expenditures. 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
  
n/a
 
ITEM 4T. CONTROLS AND PROCEDURES

As of the end of the period covered by this report, we conducted an evaluation, under the supervision and with the participation of our chief executive officer and chief financial officer of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) of the Exchange Act). Based upon this evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is: (1) accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure; and (2) recorded, processed, summarized and reported, within the time periods specified in the Commission's rules and forms. There was no change to our internal controls or in other factors that could affect these controls during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 
12


PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We are not a party to any pending legal proceeding, nor is our property the subject of a pending legal proceeding, that is not in the ordinary course of business or otherwise material to the financial condition of our business. None of our directors, officers or affiliates is involved in a proceeding adverse to our business or has a material interest adverse to our business.
 
ITEM 1A. RISK FACTORS  
 
There are no material changes from the risk factors previously disclosed in the Registrant’s Form 10-K filed on June 30, 2008.
 
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
 
None
 
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
 
None
 
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
 
None
 
ITEM 6. EXHIBITS

Exhibit No.
 
Description
     
3.1
 
Articles of Incorporation of Carbon Sciences, Inc. filed with the Nevada Secretary of State on August 25, 2007. (Incorporated by reference to the Company’s Registration Statement on Form SB-2 filed on July 27, 2007)
     
3.2
 
Articles of Amendment of Articles of Incorporation of Carbon Sciences, Inc. filed with the Nevada Secretary of State on April 9, 2007 (Incorporated by reference to the Company’s Registration Statement on Form SB-2 filed on July 27, 2007)
     
3.4
 
Bylaws of Carbon Sciences, Inc. (Incorporated by reference to the Company’s Registration Statement on Form SB-2 filed on July 27, 2007)
     
5.1
 
Opinion of Sichenzia Ross Friedman Ference LLP. (Incorporated by reference to the Company’s Registration Statement on Form SB-2 filed on July 27, 2007)
     
10.1
 
Form of Subscription Agreement dated as of September 18, 2006 (Incorporated by reference to the Company’s Registration Statement on Form SB-2 filed on July 27, 2007)
     
10.2
 
Form of Subscription Agreement dated as of October 2, 2006(Incorporated by reference to the Company’s Registration Statement on Form SB-2 filed on July 27, 2007)
     
10.3
 
Form of Subscription Agreement dated as of March 1, 2007(Incorporated by reference to the Company’s Registration Statement on Form SB-2 filed on July 27, 2007)
     
10.4
 
Form of Subscription Agreement dated as of April 16, 2007(Incorporated by reference to the Company’s Registration Statement on Form SB-2 filed on July 27, 2007)
     
31.1
 
Certification by Chief Executive Officer and Chief Financial Officer pursuant to Sarbanes-Oxley Section 302 (filed herewith).
     
32.1
 
Certification by Chief Executive Officer and Acting Chief Financial Officer pursuant to 18 U.S.C. Section 1350 (filed herewith).
 
 
13


 
 
SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Los Angeles, State of California, on November 14, 2008.

   
CARBON SCIENCES, INC.
     
 
By:
/s/ Derek W. McLeish
 
   
Chief Executive Officer (Principal Executive
Officer ) and Acting Chief Financial Officer
(Principal Financial Officer and Principal
Accounting Officer)
 
 
 
 
 
 
 
 
14